News Kraig Labs Transfers Onsite Testing and Screening of Transgenics Technology to its Prodigy subs | KBLB Message Board Posts


Kraig Biocraft Laboratories, Inc.

  KBLB website

KBLB   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  6505 of 6514  at  6/7/2021 7:06:44 AM  by

amotewm11

The following message was updated on 6/7/2021 7:08:29 AM.

News Kraig Labs Transfers Onsite Testing and Screening of Transgenics Technology to its Prodigy subsidiary

Kraig Biocraft Laboratories
Menu Skip to content
KRAIG BIOCRAFT LABORATORIES TRANSFERS ONSITE TESTING AND SCREENING OF TRANSGENICS TECHNOLOGY TO ITS PRODIGY SUBSIDIARY

Equipment transfer positions Prodigy to expedite production expansion and next-generation disease-resistant silkworms
ANN ARBOR, Mich., June 7, 2021 Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (Company or Kraig Labs), the biotechnology company focused on the development and commercialization of spider silk, announces the transfer of its onsite testing and screening of transgenics technology to Prodigy Textiles, the Companys Vietnam based subsidiary.
The Company made the significant decision to transfer testing and screening technologies from its R&D headquarters in the US to its factory in Vietnam. This testing equipment allows for precise screening and selection of the transgenics key genetic traits, which are currently conducted exclusively at the Companys US headquarters. Implementing this testing onsite eliminates the delay caused by transferring samples between the US and Vietnam and further strengthens the Companys continued production operations against future challenges related to travel restrictions. This new laboratory equipment is in addition to the recently reported production automation equipment that is being installed at the same facility.
This new testing capability will also support the Companys development program to produce new disease-resistant strains of silkworms. These new disease-resistant lines of silkworms are intended for licensing into the global market for mundane silks to combat pathogenic virus and fungi that account for the loss of approximately 20% of the typical global annual silk production.[1]
This move will dramatically increase our production efficiency and reduce costs of operations. The labs at Prodigy will be fully equipped to conduct all material performance and genetic screening in real-time. This technology transfer, coupled with the investment in equipment and staffing, will speed up our commercial production ramp-up while eliminating a log jam in operations and is expected to be online within 60 days. Simultaneously, our US R&D team will be freed to focus its attention on bringing next-generation transgenics and materials to market, said COO Jon Rice.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/n


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 9  
   Views: 0 []
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...